Skip to main content
XORTX Therapeutics Inc. logo

XORTX Therapeutics Inc. — Investor Relations & Filings

Ticker · XRTX ISIN · CA98420Q2071 LEI · 254900RAT3XZPF9F9350 US Manufacturing
Open in API
Filings indexed 263 across all filing types
Latest filing 2023-11-13 Regulatory Filings
Country CA Canada
Listing US XRTX

About XORTX Therapeutics Inc.

https://www.xortx.com/

XORTX Therapeutics Inc. is a late-stage clinical biopharmaceutical company that develops and commercializes therapies for diseases associated with aberrant purine metabolism and high serum uric acid. The company's pipeline focuses on progressive kidney diseases, including Autosomal Dominant Polycystic Kidney Disease (ADPKD), Type 2 Diabetic Nephropathy (T2DN), and Acute Kidney Injury (AKI), as well as gout. Its lead program, XRx-008, is in development for the treatment of ADPKD.

Recent filings

Filing Released Lang Actions
FORM 6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It includes a signature from the CEO and references an attached press release (Exhibit 99.1). The document length is short (1237 characters), and it primarily serves as a regulatory filing to report current information, including the press release. There is no substantive financial data or detailed report content within this text. According to the rules, Form 6-K filings are considered Regulatory Filings (RNS) as they are miscellaneous filings that do not fit into other specific categories and often include current event disclosures or press releases.
2023-11-13 English
FORM 6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It includes a press release as an exhibit but does not contain detailed financial statements or substantive financial data. The document length is short (1232 characters), and it primarily serves as a regulatory filing to report current events or updates. According to the rules, such filings that do not contain full financial reports or detailed analysis are classified as Regulatory Filings (RNS).
2023-11-08 English
FORM 6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC under the Securities Exchange Act of 1934. It includes a press release as an exhibit but does not contain detailed financial statements or substantive financial data. The document length is short (1232 characters), and it primarily serves as a regulatory filing to disclose information to the SEC and investors. According to the classification rules, Form 6-K filings are best categorized under Regulatory Filings (RNS) as they are general regulatory announcements and do not constitute full annual or interim reports.
2023-11-02 English
FORM 6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC under the Securities Exchange Act of 1934. It includes a signature from the CEO and references an attached press release (Exhibit 99.1) dated October 27, 2023. The document length is short (1231 characters), and it primarily serves as a regulatory filing to report current information rather than a full financial report or detailed presentation. There is no substantive financial data or detailed report content, only a notification of a press release. According to the rules, such filings are classified as Regulatory Filings (RNS) when they do not fit other categories and are brief notices or attestations.
2023-10-27 English
FORM 6-K
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It is dated October 2023 and signed by the CEO. The document is very short (1089 characters) and includes an exhibit index referencing a 'Report of Voting Results'. There is no substantive financial data or detailed report content, only a filing notice and a reference to voting results. According to the rules, short documents announcing or filing voting results should be classified as Declaration of Voting Results & Voting Rights Announcements (DVA).
2023-10-27 English
FORM 6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, XORTX Therapeutics Inc., pursuant to SEC rules. It is a regulatory filing used to report material information between annual reports (Form 20-F or 40-F). The document is short (1011 characters) and includes a signature and an exhibit index referencing a news release. There is no substantive financial data or detailed report content, only a notification filing. Therefore, it fits the category of Regulatory Filings (RNS) as a general SEC filing that does not fit other specific categories.
2023-10-25 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.